StoryPartnership
Takeda deploys Boltz biomolecular AI models across its discovery organization
BoltzBoltz-2 / BoltzGen open models
Takeda Pharmaceutical announced a research collaboration to deploy Boltz models across its discovery organization for structure prediction, binding affinity estimation, and molecular design in preclinical research.